Status:
UNKNOWN
AQP-1 Polymorphism on Fluid Status in Hemodialysis Patients
Lead Sponsor:
RenJi Hospital
Conditions:
End Stage Renal Disease on Dialysis
Eligibility:
All Genders
18-70 years
Brief Summary
It is a cross sectional observational study. It is to investigate whether AQP-1 polymorphism has any impact on fluid status in hemodialysis patients. The long term stable HD patients in the current ce...
Eligibility Criteria
Inclusion
- age 18-70
- ESRD
- maintained HD
- no target weight change during the last week of entering the study and achieve target weight at the end of HD section
- informed consented
Exclusion
- expected survival time less than 3 months
Key Trial Info
Start Date :
December 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05275387
Start Date
December 1 2022
End Date
February 28 2023
Last Update
November 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital
Shanghai, Shanghai Municipality, China, 201204